Publication | Closed Access
Selected CD133 <sup>+</sup> Progenitor Cells to Promote Angiogenesis in Patients With Refractory Angina
66
Citations
28
References
2014
Year
Our findings support feasibility and safety of transendocardial injection of CD133(+) cells in patients with refractory angina. The promising clinical results and favorable data observed in SPECT summed score may set up the basis to test the efficacy of cell therapy in a larger randomized trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1